Detalles de la búsqueda
1.
Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer.
Clin Pharmacol Ther
; 115(3): 468-477, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776107
2.
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn Disease.
J Clin Pharmacol
; 63(8): 928-942, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060327
3.
Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.
Target Oncol
; 18(5): 667-684, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713090
4.
Population-based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma.
Clin Transl Sci
; 15(12): 3000-3011, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36204820
5.
Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis.
Clin Pharmacokinet
; 58(11): 1455-1467, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31055792
6.
A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin's lymphoma weighing ≤70 kg.
Bone Marrow Transplant
; 54(2): 258-264, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29895931
7.
Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer.
Cancer Lett
; 253(1): 115-23, 2007 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-17349740
8.
Using novobiocin as a specific inhibitor of breast cancer resistant protein to assess the role of transporter in the absorption and disposition of topotecan.
J Pharm Pharm Sci
; 10(4): 519-36, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18261372
9.
Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?
Expert Opin Drug Deliv
; 3(3): 419-35, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16640501
10.
Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance.
Eur J Pharm Sci
; 29(2): 102-10, 2006 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16844360
11.
Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
AAPS J
; 17(2): 462-73, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25630504
12.
Galanin down-regulates microglial tumor necrosis factor-alpha production by a post-transcriptional mechanism.
J Neuroimmunol
; 134(1-2): 52-60, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12507772
13.
The A to G polymorphism at -1082 of the interleukin-10 gene is rare in the Han Chinese population.
Mol Med Rep
; 6(4): 894-6, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22825546
14.
Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
Mol Pharm
; 1(1): 49-56, 2004 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15832500
15.
Practical aspects of transporter model systems: a case study involving SQV.
Drug Metab Rev
; 36(2): 377-89, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15237860
16.
Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells.
Mol Pharm
; 1(2): 145-55, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15832511
Resultados
1 -
16
de 16
1
Próxima >
>>